| Allelic loss of DNA locus of the RET proto-oncogene in small cell lung cancer. | lung, |
| Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model. | thyroid, |
| [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor]. | thyroid, |
| mutations of the RET protooncogene were analyzed in Russian patients with inherited or sporadic medullary thyroid carcinoma.The most common mutation affected codon 918 to cause substitution of methionine with threonine and accounted for 31.6% alleles. | thyroid, |
| Inactivation of Ret/Ptc1 oncoprotein and inhibition of papillary thyroid carcinoma cell proliferation by indolinone RPI-1. | thyroid, |
| Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients. | neuroblastoma,thyroid, |
| Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A. | PCPG,thyroid, |
| Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. | thyroid, |
| Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. | thyroid, |
| Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation. | thyroid, |
| Point mutation in exon 14 at codon 804 of the RET proto-oncogene locus in a case of lymph node metastases of medullary and papillary thyroid carcinoma. | thyroid, |
| The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma. | thyroid, |
| association of high-level Ret proto-oncogene protein expression with neuronal morphology suggests that the variable overexpression of Ret in pheochromocytomas might in part be an epiphenomenon, reflecting the known phenotypic plasticity of these tumors | PCPG, |
| Ret protein expression in adrenal medullary hyperplasia and pheochromocytoma. | PCPG,kidney, |
| RET oncogene expression of papillary thyroid carcinoma in Korea. | thyroid, |
| RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. | thyroid, |
| The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. | thyroid, |
| Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. | thyroid, |
| Selective disruption of oncogenic RET signaling in medullary thyroid carcinoma in vitro and in vivo is associated with loss of the neoplastic phenotype of medullary thyroid carcinoma. | thyroid, |
| [Advances of RET oncogene activation in papillary thyroid carcinoma]. | thyroid, |